Who
Mark Altmeyer
Director
Company insider
Files Form 4 as: Director, Alector; Director, Myovant Sciences; Pres (ASG) & Chief Comm. Ofc., Axovant Sciences.
In numbers
- Trades disclosed
- 17
- Buys
- 2
- Sells
- 0
- Bought
- $72K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 10 Mar 2016
- Last trade
- 17 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 17 Jun 2026 | ALEC AlectorBiotechnology | SEC FORM 4 Code A | —28,700 at $0.00 | filing |
| 17 Jun 2026filed 17 Jun 2026 | ALEC Alectoroption or derivative · Biotechnology | SEC FORM 4 Code A | —9,450 at $0.00 | filing |
| 17 Jun 2026filed 17 Jun 2026 | ALEC Alectoroption or derivative · Biotechnology | SEC FORM 4 Code A | —9,450 at $0.00 | filing |
| 17 Jun 2026filed 17 Jun 2026 | ALEC AlectorBiotechnology | SEC FORM 4 Code A | —28,700 at $0.00 | filing |
| 11 Jun 2025filed 12 Jun 2025 | ALEC Alectoroption or derivative · Biotechnology | SEC FORM 4 Code A | —9,450 at $0.00 | filing |
| 11 Jun 2025filed 12 Jun 2025 | ALEC AlectorBiotechnology | SEC FORM 4 Code A | —28,700 at $0.00 | filing |
| 19 Mar 2024filed 21 Mar 2024 | ALEC Alectoroption or derivative · Biotechnology | SEC FORM 4 Code A | —19,420 at $0.00 | filing |
| 19 Mar 2024filed 21 Mar 2024 | ALEC AlectorBiotechnology | SEC FORM 4 Code A | —41,250 at $0.00 | filing |
| 31 Aug 2018filed 4 Sep 2018 | Myovant Sciencesoption or derivative | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 15 Mar 2018filed 16 Mar 2018 | Axovant Sciencesoption or derivative | SEC FORM 4 Code A | —340,000 at $0.00 | filing |
| 15 Mar 2018filed 16 Mar 2018 | Axovant Sciencesoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 17 Nov 2017filed 15 Jun 2018 | Myovant Sciences | SEC FORM 4 Bought | $47K3,500 at $13.38 | filing |
| 18 Aug 2017filed 20 Oct 2017 | Myovant Sciencesoption or derivative | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 15 May 2017filed 17 May 2017 | Myovant Sciencesoption or derivative | SEC FORM 4 Code A | —11,154 at $0.00 | filing |
| 28 Apr 2017filed 2 May 2017 | Axovant Sciencesoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 29 Apr 2016filed 3 May 2016 | Axovant Sciencesoption or derivative | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 10 Mar 2016filed 14 Mar 2016 | Axovant Sciences | SEC FORM 4 Bought | $26K2,300 at $11.14 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.